Hansa Biopharma AB, ("Hansa" or "the Company"), , today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for imlifidase. The Company is ...
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...
HOUSTON, Texas (KTRK) -- The ABC13 Houston 24/7 streaming channel gives you free access to ABC13 Houston News and your favorite Eyewitness News content, along with breaking news, live events, and ...
There are tons of brilliant open-source apps. You'll find open-source titles for Linux, MacOS, and Windows. Some of these apps are so good, they should have a price tag. Since I started my journey ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...
Ben Khalesi covers the intersection of artificial intelligence and everyday tech at Android Police. With a background in AI and data science, he enjoys making technical topics approachable for those ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a historic agreement with the Trump administration to ensure its prescription medicines are both accessible and ...
Discover the top 3 undervalued Automobile Components stocks for Friday, December 26 based on AAII’s Stock Grades.
Many popular apps collect more of your personal data than necessary to function properly. These 20 apps quietly scoop up your photos, location, contacts, and more. Here's how to protect yourself. I ...
AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab has been approved in the US for the 1st-line treatment of adult patients with unresectable or ...
I’m not a big fan of the subscription economy. It seems like most apps are trying to get us to pay a monthly — or yearly — subscription these days, a stark contrast to the times when getting full ...